Symbols

ZYME

Zymeworks·NASDAQ

--(--)

ZYME Profile

Zymeworks Inc.

A company that develops multifunctional biotherapeutics for the treatment of cancer

Industry

Pharmaceutical

Established Date

Listing Date

12/16/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

264

Fiscal Year Ends

12-31

Website

www.zymeworks.com

Security Type

Common stock

Office address

108 Patriot Drive — Suite A, Middletown, Delaware 19709

Business

Introduction

Zymeworks Inc., was incorporated under the laws of the State of Delaware in June 2022. The company is a global biotechnology company that manages a portfolio of licensed medical assets and develops novel biotherapeutic product lines for cancer, inflammation and autoimmune diseases. Its strategy combines royalty aggregation, strategic acquisitions and internal innovation, and is underpinned by its proprietary multispecific antibody and antibody-drug conjugate technology platform.